Clinical Trial: Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome

U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07240376) titled 'Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome' on Sept. 30.

Brief Summary: The goal of this clinical trial is to learn if Stapokibart (CM310) works to treat Non-Allergic Rhinitis with Eosinophilia Syndrome (NARES) in adults. It will also learn about the safety of CM310.

The main questions it aims to answer are:

Does drug CM310 relieve the symptoms of participants? What medical problems do participants have when injecting CM310? Researchers will compare CM310 to a placebo (a look-alike substance that contains no drug) to see if CM310 works to treat NARES.

Participants will:

Inject CM310 or...